Lung cancer patients often face a tough trio of symptoms: fatigue, pain, and sleep disturbances. These issues don't just happen alone; they're linked, creating a cluster of problems that can make life even harder for those already battling cancer. Researchers wanted to understand this cluster better. They studied 310 lung cancer patients undergoing treatment. They u...

Asciminib is a drug that has been making waves in the treatment of chronic myeloid leukemia (CML). The ASC4FIRST study is a phase III trial that compared asciminib with other tyrosine kinase inhibitors (TKIs) chosen by doctors. The results were impressive, showing that asciminib was more effective and had better safety and tolerability. This trial included a subgr...